Estimation of radiation-induced second cancer risk associated with the institutional field matching craniospinal irradiation technique: A comparative treatment planning study
- PMID: 31333335
- PMCID: PMC6617103
- DOI: 10.1016/j.rpor.2019.06.004
Estimation of radiation-induced second cancer risk associated with the institutional field matching craniospinal irradiation technique: A comparative treatment planning study
Abstract
Aim: To estimate and compare the lifetime attributable risk (LAR) of radiation-induced second cancer (SC) in pediatric medulloblastoma patients planned with institutional 3D conformal field matching method, gap junction method and Intensity Modulated Radiotherapy (IMRT).
Background: The epidemiological studies on childhood cancer survivors reported that long-term cancer survivors who received radiotherapy are at a significantly increased risk for the development of SC. Hence, the increased concern to predict the SC risk for long-term survivors.
Materials and methods: In addition to institutional field matching planning method, IMRT and gap junction methods were created for ten pediatric medulloblastoma patients. The risk estimates were made based on the site-specific cancer risk coefficient provided by the BEIR VII committee according to the organ equivalent dose for various critical organs. Also, plans were compared for target volume dose distribution and dose received by critical organs.
Results: When compared to the gap junction method, the IMRT and institutional field matching method were superior in normal tissue sparing and dose conformity. However, highly significant volume of low dose associated with IMRT was the main concern for the SC risk. The accumulated LAR for all the critical organs with 3D conformal gap junction and IMRT method was 23-25% while for the 3D conformal field matching method it was 21%.
Conclusion: The LAR associated with the institutional field matching technique was substantially lower. As this method is highly robust and easy to set up, it can be a better choice of a craniospinal irradiation technique where 3DCRT is the only choice of treatment.
Keywords: BEIR; Craniospinal irradiation; Field matching; Organ equivalent dose; Second cancer.
Figures






Similar articles
-
Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):362-72. doi: 10.1016/j.ijrobp.2005.01.060. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168831
-
A three-isocenter jagged-junction IMRT approach for craniospinal irradiation without beam edge matching for field junctions.Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):648-54. doi: 10.1016/j.ijrobp.2012.01.010. Epub 2012 Mar 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22436794
-
Optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction(s).Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1405-14. doi: 10.1016/j.ijrobp.2010.07.1987. Epub 2011 Feb 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 21300472
-
The risk of secondary cancer in pediatric medulloblastoma patients due to three-dimensional conformal radiotherapy and intensity-modulated radiotherapy.Indian J Cancer. 2018 Oct-Dec;55(4):372-376. doi: 10.4103/ijc.IJC_410_18. Indian J Cancer. 2018. PMID: 30829273
-
A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.Acta Oncol. 2007;46(4):462-73. doi: 10.1080/02841860701218626. Acta Oncol. 2007. PMID: 17497313 Review.
Cited by
-
Nontarget and Out-of-Field Doses from Electron Beam Radiotherapy.Life (Basel). 2022 Jun 8;12(6):858. doi: 10.3390/life12060858. Life (Basel). 2022. PMID: 35743890 Free PMC article.
-
Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.J Radiat Res. 2021 Mar 10;62(2):186-197. doi: 10.1093/jrr/rraa118. J Radiat Res. 2021. PMID: 33341899 Free PMC article. Clinical Trial.
References
-
- Nell M.C., Cot T.R., Clegg L., Rorke L.B. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor; a SEER update. Med Pediatr Oncol. 2002;39:190–194. - PubMed
-
- Monteith S.J., Heppner P.A., Wood field M.J., Law A.J.J. Pediatric central nervous system tumours in a new Zealand population; a 10 year experience of epidemiology, management and outcomes. J Clin Neurosci. 2006;13:722–729. - PubMed
-
- Suh Y.I., Koo H., Kim T.S. Tumours of the central nervous system in Korea; a multicenter study of 3221 cases. J Neurooncol. 2002;56:251–259. - PubMed
-
- Chan M.Y., Teo W.Y., Soow W.T., Tan A.M. Epidemiology management and treatment outcome of medulloblastoma in Singapore. Ann Acad Med Singapore. 2007;36(5):314–318. - PubMed
-
- Ozek M.M., Cinalli G., Maixner W., Rose C.S. 2000. Posterior fossa tumors in children. New York.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous